Transluminal Technologies focuses on the development of novel, minimally invasive
cardiovascular devices using proprietary absorbable biometals
Our Products
A first-of-its-kind magnesium alloy-based vascular closure device that offers a unique method of quickly achieving stable mechanical vascular closure following percutaneous catheterization for diagnostic or interventional procedures using 5-8 Fr procedural sheaths.
A revolutionary large bore vascular closure device that leverages the technology from velox CD™ for 12-18 Fr percutaneous structural heart procedures (TAVR, EVAR, etc.)
*For investigational use only